Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Montelukast for treatment of cystitis in children with allergy history
IRCT20220203053919N1Phase 3Completed
- Sponsor
- Arak University of Medical Sciences
- Start
- Mar 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of montelukast in cystitis (2 arms), sponsored by Arak University of Medical Sciences. Primary endpoints: Dysuria, Urinary frequency and 3 more. Started Mar 2022; status: completed.
02
Drugs
montelukast
03
Conditions
cystitis
Beyond the preview
Go deeper on IRCT20220203053919N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20220203053919N1.